The growing number of Australians with obesity is causing economic damage but should the taxpayer fund weight-loss drugs?
The Canadian Press on MSN10h
Canadian scientist wins Breakthrough Prize for discovery of hormone used in Ozempic, MounjaroA Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes ...
The Centers for Medicare & Medicaid Services will not cover drugs when exclusively used for weight loss, like Ozempic or Wegovy, the Trump administration announced.
Advances recognized by science’s most lucrative awards include Large Hadron Collider experiments and groundbreaking ...
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...
It’s why Webb, of Rochester, is fighting for the passage of Indiana Senate Bill 140. The bill, which passed the Indiana ...
Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.
Trump previously floated a 25% tariff on all imported drugs, though they were unaffected by recent reciprocal levies.
Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.
Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...
At the helm of Denmark’s economic success is Novo Nordisk, the pharma company that makes Ozempic and Wegovy, blockbuster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback